.png)
PetVivo Cares is an organization that cares about the health of animals and the happiness of their owners. That's why we're so excited to share this story with you:
Kona is a young Labrador puppy who had to be rescued from a life of pain, lameness, and inability to run with her friends after she was diagnosed with elbow dysplasia at eight months old!
Her owner goes on mountain runs every morning, about 5 or 6 times a week. It was suggested to her owner that they should do a treatment of Spryng. Even though she recovered a little slower than most animals and needed a second joint injected, she is doing amazing and loves her morning runs, chases rabbits, and is happier than ever! The rabbits always win the race!
This is an amazing story because it shows how Spryng™ can help even the smallest animals live their lives full of joy and adventure!
PetVivo Cares provides treatments of Spryng™ at a reduced cost or at no cost to animals in need. We feel strongly that all animals should have access to Spryng regardless of their
Would you like to help more animals like Kona?
When you make the decision to donate to PetVivo Cares you are helping support animals just like Kona. We will send you our monthly newsletter so you can get to know the lucky recipients of the PetVivo Cares Grants - so you can see where your money is going.
Want the technical info? Read Below!
CONDITION
Degenerative Joint Disease in bilateral elbows and stifles.
In May 2008, Doc had left patellar luxation repair, then tore his cranial cruciate ligament (CCL) and had an extracapsular repair in December of the same year. In May of 2009, Doc sustained a right CCL rupture and concomitant patellar luxation. His right leg was repaired via TPLO with trocheoplasty and tibial tuberosity transposition. In November 2009, Doc started Carprofen for stifle arthritis and also received Rimadyl®, Previcox® or Deramaxx® most of the time since then. He receives eight Adequan® injections two to three times per year.
TREATMENT
In October 2015, Doc received Propofol as an induction agent and anesthesia was maintained with isoflurane and oxygen. His radiographs revealed moderate bilateral hip dysplasia with severe DJD in both stifles and elbows. In the left stifle, 0.25 cc of joint fluid was extracted using a 20 gauge 1 ⅔ inch needle, and 0.5 cc Triamcinolone was infused followed by 1.6 cc Spryng™ with OsteoCushion™ Technology. In his left elbow, 0.2 cc of joint fluid was extracted with a 20 gauge 1 ½ inch needle and 0.5 cc Triamcinolone was infused followed by 0.8 cc Spryng™ with OsteoCushion™ Technology. In the right stifle, 0.1 cc of synovial fluid was extracted using a 20 gauge 1 ⅔ inch needle, and 0.5 cc Triamcinolone was infused followed by 1.6 cc Spryng™ with OsteoCushion™ Technology. In the right elbow, 0.15 cc of joint fluid was extracted using a 20 gauge 1 ⅔ inch needle, and 0.5 cc Triamcinolone was infused followed by 0.8 cc Spryng™ with OsteoCushion™ Technology.
RESULTS
One week following the injection, Kona demonstrated a grade 1 lameness, which was a significant improvement. I saw her the next afternoon after a morning mountain run and she was a very mild grade 2 — at least a full lameness grade improvement over the pre-injection, post-run lameness score. She continued to improve over the next 7-10 days and stabilized at a grade 1 lameness (slight intermittent limp, with an occasional subtle head bob). She remained at this level until February of 2016, despite vigorous mountain runs at least 4-5 days a week.
